WESPAC Advisors SoCal’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-306
Closed -$49K – 123
2019
Q1
$49K Hold
306
– – 0.03% 118
2018
Q4
$47K Buy
306
+50
+20% +$7.79K 0.03% 124
2018
Q3
$38K Buy
+256
New +$36.4K 0.02% 141
2018
Q2
– Sell
-256
Closed -$34K – 118
2018
Q1
$34K Hold
256
– – 0.02% 127
2017
Q4
$38K Hold
256
– – 0.02% 124
2017
Q3
$33K Hold
256
– – 0.02% 137
2017
Q2
$34K Hold
256
– – 0.02% 129
2017
Q1
$34.5K Hold
256
– – 0.02% 127
2016
Q4
$30.8K Sell
256
-100
-28% -$11.8K 0.02% 133
2016
Q3
$44.6K Hold
356
– – 0.03% 117
2016
Q2
$49.3K Buy
356
+100
+39% +$13K 0.03% 119
2016
Q1
$32.3K Hold
256
– – 0.02% 131
2015
Q4
$32K Buy
+256
New +$31.8K 0.02% 143

Other funds holding CLX

WESPAC Advisors SoCal's CLX Position: Q2 2019 in Review

WESPAC Advisors SoCal sold out of Clorox (CLX) in Q2 2019, closing a stake of 306 shares — an estimated $49K sold.

WESPAC Advisors SoCal first reported a position in CLX in Q4 2015 and held it in 13 quarters. The position peaked at $49.3K in Q2 2016. 966 funds tracked by Wall St. Rank hold CLX as of Q2 2019.

  • WESPAC Advisors SoCal reported no remaining Clorox position as of Q2 2019 after selling out during the quarter.
  • WESPAC Advisors SoCal sold 306 Clorox shares in Q2 2019, an estimated $49K.
  • WESPAC Advisors SoCal first reported a position in Clorox in Q4 2015 and held it in 13 quarters.
  • WESPAC Advisors SoCal's Clorox position peaked at $49.3K in Q2 2016.
  • 966 funds tracked by Wall St. Rank held Clorox as of Q2 2019.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2019, filed 30 Jul 2019.